Coursera Plus Annual is 40% Off — Ends July 6.

Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

The Era of ADCs in the Treatment of NSCLC

HMP Education via YouTube

Start learning Write review
CodeSignal Ad

Learn the Skills Netflix, Meta, and Capital One Actually Hire For

Learn More → Boot.dev Ad

Stuck in Tutorial Hell? Learn Backend Dev the Right Way

Learn More →

Overview

AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Explore the evolving landscape of antibody-drug conjugates (ADCs) in non-small cell lung cancer (NSCLC) treatment through this informative 33-minute video. Gain insights into the latest advancements, clinical applications, and potential benefits of ADCs in improving outcomes for NSCLC patients. Delve into the mechanisms of action, efficacy data, and safety profiles of emerging ADC therapies. Understand how these targeted treatments are reshaping the therapeutic approach to NSCLC and their implications for patient care. Healthcare professionals can earn Continuing Medical Education (CME) credits by completing the associated program.

Syllabus

The Era of ADCs in the Treatment of NSCLC

Taught by

HMP Education

Reviews

Start your review of The Era of ADCs in the Treatment of NSCLC

Start learning

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Sign up for free
Someone learning on their laptop while sitting on the floor.